Psychedelics educational platform giving professional training and certification in psychedelic therapy and psychedelic integration for healthcare workers Fluence announced having closed an investment round aimed at raising funds to ramp up the company’s expert driven training platform through widening its e-learning capacity.
The company says it raised $1.6 million from investment firms; Neo Kuma Ventures, JLS Fund and Palo Santo who co-led the investment round.
The company is aiming at training healthcare providers on how they can safely and effectively administer psychedelic therapies to patients suffering from mental health conditions.
This development seems to support a recent report by Nature Medicine which said most physicians who wish to incorporate psychedelics in their nature of work need some training as it’s essential to come up with evidence based clinical practical guidelines.
The company’s co-founder, Elizabeth Nielson, says the company is currently training therapists for on Tryp Therapeutics’ phase 2a clinical trial of psilocybin for treatment of eating disorders further adding that the company will be announcing more partnerships in the near future.
“Fluence grew out of our natural response to interest in high-quality professional education about psychedelic therapy. Bringing our expertise from multiple psychedelic therapy clinical trials and research leadership positions, our team delivers meaningful, engaging, and impactful training experiences to individual therapists and entire research teams. We look forward to implementing the expansion that this funding will allow and welcoming the next generation of therapists to our field,” added Nielson.